Spanish Research Confirms CCP Virus & Vaccine Can Activate Multiple Human Herpes Viruses

On February 10, a peer-reviewed research paper published by Miguel Servet University Hospital in Spain found that the infection and vaccination of the Chinese Communist Party virus, or in short, the CCP-virus, could induce the reactivation of different subtypes of Human Herpes Viruses, HHVs.

Previously, there were research papers confirmed that the CCP-virus and its vaccine could trigger Herpes Simplex Virus (HSV) types-1(HSV-1) and type 2 (HSV-2); Varicella-Zoster Virus (VZV); Epstein-Barr Virus (EBV); this study further shows that other types of HHVs can also be activated, including some herpes viruses that can lead to serious complications.

In order to acquire a complete understanding of the possible link between the CCP virus vaccination or infection and HHVs co-infection or reactivation, the research team conducted a review on each member of the HHVs family.

The results show that not only the CCP-virus, but also all approved vaccines will induce the reactivation of various herpes viruses. Among them, the most worrying are the Cytomegalovirus(CMV); HHV-6; HHV-7; and HHV-8. Once infected, they may trigger other serious complications such as Alzheimer’s disease. For instance, the reactivation of HHV-8, also known as Kaposi’s sarcoma-associated herpesvirus or KSHV by the CCP-virus vaccine is a chilling problem. Unlike other herpes viruses, KSHV is a carcinogenic virus and an etiologic agent of several human cancers, including Kaposi Sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. It is also related to a herpes-associated inflammatory cytokine syndrome called Kaposi sarcoma virus, and for some patients, the mortality rate is very high.

According to the research team, herpes symptoms can be regarded as both a prognostic marker of infection with the CCP-virus or a symptom of vaccine side effects. Therefore, the researchers emphasize that anyone who used to be infected with the CCP-virus or received the vaccine must pay attention to the outbreak of the herpes virus so as to avoid delaying the treatment.